Multiple training interventions significantly improve reproducibility of PET/CT-based lung cancer radiotherapy target volume delineation using an IAEA study protocol  by Konert, Tom et al.
Radiotherapy and Oncology 121 (2016) 39–45Contents lists available at ScienceDirect
Radiotherapy and Oncology
journal homepage: www.thegreenjournal .comPET/CT target delineationMultiple training interventions significantly improve reproducibility of
PET/CT-based lung cancer radiotherapy target volume delineation using
an IAEA study protocolhttp://dx.doi.org/10.1016/j.radonc.2016.09.002
0167-8140/ 2016 The Authors. Published by Elsevier Ireland Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
⇑ Corresponding author at: Centre for Cancer Research and Cell Biology, Queen’s
University of Belfast, 97 Lisburn Road, Belfast BT9 7AE, Northern Ireland, United
Kingdom.
E-mail address: g.hanna@qub.ac.uk (G.G. Hanna).Tom Konert a,b, Wouter V. Vogel a,b, Sarah Everitt c, Michael P. MacManus c, Daniela Thorwarth d,
Elena Fidarova e, Diana Paez e, Jan-Jakob Sonke b, Gerard G. Hanna f,⇑
aNuclear Medicine Department; bDepartment of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands; cDivision of Radiation Oncology, Peter MacCallum
Cancer Centre, East Melbourne, Australia; dDepartment of Radiation Oncology, University Hospital Tübingen, Germany; eDepartment of Nuclear Sciences and Application,
International Atomic Energy Agency, Vienna, Austria; and fCentre for Cancer Research and Cell Biology, Queen’s University of Belfast, United Kingdom
a r t i c l e i n f oArticle history:
Received 6 May 2016
Received in revised form 1 September 2016
Accepted 4 September 2016
Available online 20 September 2016
Keywords:
Lung cancer
PET/CT
Radiation treatment planning
Radiotherapy
Target volume delineation
Training interventionsa b s t r a c t
Background and purpose: To assess the impact of a standardized delineation protocol and training inter-
ventions on PET/CT-based target volume delineation (TVD) in NSCLC in a multicenter setting.
Material and methods: Over a one-year period, 11 pairs, comprised each of a radiation oncologist and
nuclear medicine physician with limited experience in PET/CT-based TVD for NSCLC from nine different
countries took part in a training program through an International Atomic Energy Agency (IAEA) study
(NCT02247713). Teams delineated gross tumor volume of the primary tumor, during and after training
interventions, according to a provided delineation protocol. In-house developed software recorded the
performed delineations, to allow visual inspection of strategies and to assess delineation accuracy.
Results: Following the first training, overall concordance indices for 3 repetitive cases increased from
0.57 ± 0.07 to 0.66 ± 0.07. The overall mean surface distance between observer and expert contours
decreased from 0.40 ± 0.03 cm to 0.01 ± 0.33 cm. After further training overall concordance indices
for another 3 repetitive cases further increased from 0.64 ± 0.06 to 0.80 ± 0.05 (p = 0.01). Mean surface
distances decreased from 0.34 ± 0.16 cm to 0.05 ± 0.20 cm (p = 0.01).
Conclusion: Multiple training interventions improve PET/CT-based TVD delineation accuracy in NSCLC
and reduce interobserver variation.
 2016 The Authors. Published by Elsevier Ireland Ltd. Radiotherapy and Oncology 121 (2016) 39–45 This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Lung cancer is the most common cause of death from cancer
worldwide, estimated to be responsible for nearly 17% of the total
[1] and it is estimated that more than 80% of patients in low and
middle income countries are diagnosed with lung cancer in an
advanced stage (III and IV) [2,3]. The use of fused 18F-
fluorodeoxyglucose Positron Emission Tomography/Computed
Tomography (FDG-PET/CT) imaging is now the standard method
of acquiring FDG-PET images for the purpose of baseline staging
and RT treatment preparation [4], since it has been shown to be
superior to either PET or CT alone [5,6]. The number of PET/CT
scanners has increased in low and middle income countries in
the last decade [7] and additional training in the use of PET/CT in
radiotherapy planning (RTP) is vital to ensure appropriate interpre-tation of PET/CT with the hope, that the use of PET/CT will improve
outcomes for patients treated with radiotherapy.
Due to advancements in radiotherapy techniques, accuracy in
treatment delivery is improving and precise target volume defini-
tion has become more important, particularly in the era of dose
escalation [8,9]. However, gross tumor volume (GTV) delineation
is very sensitive to observer variation [10] and hence there is a
potential risk of geographic miss of tumor [11]. PET has been shown
to have a significant impact when used in the radiation treatment
planning process and in particular when used for target volume
delineation (TVD), where a significant reduction in interobserver
variability (IOV) has been noted [11–15]. It is recommended that
a radiation oncologist (RO) and a nuclear medicine physician
(NMP)/PET radiologist should be both involved where PET is used
for TVD [16,17]. Complex cases of GTV delineation in lung cancer
patients should always be discussed in a multi-disciplinary quality
control meeting. Most clinical studies have used a visual interpreta-
tion technique, while others have reported the use of a range of
40 Multiple training improves PET/CT based target volume delineation in lung cancerautomated segmentation techniques to either guide or generate the
relevant target volume [18–21]. There is no clear consensus on
which method most closely approximates to the tumor position
and tumor edge, and pathological correlation has proven difficult
[22]. Preoperative PET imaging shows a remarkably good correla-
tion with resected pathological specimens [23], although it is
acknowledged that those specimens are affected by processing arti-
facts. Most recent guidance advises the use of visual interpretation
of the PET signal when drawing the final contour, even in cases
where auto-contouring is used to generate an initial draft for edit-
ing, if PET is to be used to inform the target volume [17].
Factors causing IOV in TVD are variable interpretation of guide-
lines, lack of differentiation between normal structures and tumor,
incorrect interpretation of radiological images, lack of knowledge
in cross sectional radiological anatomy, and suboptimal imaging
techniques e.g. lack of IV contrast [24–26]. The use of a rigorous
contouring protocol in which clinicians follow a detailed set of
instructions and the use of a teaching intervention may help in
minimizing IOV [21,31,32,34,35]. To ensure adequate and repro-
ducible visual interpretation and application of PET images for
RTP, this procedure should be standardized. A recent publication
provided guidance on the use and role of PET/CT imaging for RTP
in NSCLC patient [17]. This study evaluates the impact on the use
of these practical guidelines through active teaching using multiple
training interventions involving multiple centers with minimal
experience in PET/CT-based TVD.Methods
Target volume delineation assignments
PET/CT-based TVD was assessed through the use of repeated
delineation assignments. In all contouring assignments a team
consisting of a RO and a NMP were asked to delineate tumor vol-
umes of primary tumor (GTV). Before the training, participants
were asked to delineate as per their local delineation protocol
and then again after the first training intervention according to a
standardized delineation protocol [17]. Fully anonymized patient
cases were used, including three dimensional FDG-PET and CT
image data sets acquired for the purpose of radiotherapy planning.
No intravenous contrast agent was used. Comprehensive case
specific medical reports were included in all assignments to avoid
bias due to incorrect diagnosis. An overview of the patient cases
used during this training program is given in Table 1. In each case
two senior ROs and a senior NMP delineated one reference ‘expert’
contour (GTVexp) in agreement in the absence of a histopathologi-
cally proven gold standard.Table 1
Sequence of events and characteristics of the included patients. Abbreviations: T = Primar
Case number T
Contouring Assignment 1 1 2
2 2
Contouring Assignment 2 3 3
4 2
5 4
Training 1 6 3
7 3
8 1
Contouring Assignment 3 Consisting of cases 3, 4 and 5 (repeat assig
Practice 9 2
10 2
11 2
Training 2 Webinar/feedback reports
Contouring Assignment 4 Consisting of cases 1, 6 and 7 (repeat assigParticipants
The participants in this study were from eleven medical centers
from nine different countries (Brazil, Estonia, India, Jordan,
Pakistan, Poland, Turkey, Uruguay, and Vietnam). Each center
was represented by a RO and a NMP. Before the training program
centers were asked if they already performed PET/CT-based RTP.
Five out of eleven centers already had limited experience in TVD
with PET/CT. Other centers used PET/CT imaging for diagnostic
and staging purposes only. Participants were not able to see
delineations of other centers.Big Brother target volume delineation software
Software developed in the Netherlands Cancer Institute, called
Big Brother, was used throughout this multicenter study as plat-
form for image viewing and analysis, and TVD in FDG PET/CT imag-
ing [10]. As soon as the observer starts the Big Brother software
and initiates TVD, any interaction with the software is recorded
such as mouse motion, window/level and use of delineation tools.
This feature allows visual inspection of strategies and comparison
with expert contours to assess delineation accuracy.Target volume delineation training program
The training program consisted of four contouring assignments,
two training events and three additional clinical cases for practice
(see Fig. 1). Contouring assignments 1 and 2 were performed
before the first training event without the use of a standardized
delineation protocol and were used as a baseline measurement.
The first training event was face-to-face over a three-day period
and included various lectures about relevant topics in nuclear
medicine and radiation oncology and a delineation workshop on
the use of PET/CT for RTP in NSCLC. The delineation workshop con-
tained three more clinical cases which were again performed with-
out the IAEA delineation protocol. The delineation protocol as
described in the IAEA consensus document was introduced during
the workshop [17]. The differences between the results and the
IAEA protocol constituted the basis for a teaching discussion, con-
sequentially clarifying protocol ambiguities. More contouring
assignments followed after this training to evaluate its impact on
delineation accuracy and IOV. Contouring assignment 3 was per-
formed three months after contouring assignment 2 and contained
the same clinical cases. To allow the participants to practice more
with the delineation protocol three additional clinical cases were
added.
After results were obtained from the above described assign-
ments, an interim analysis was performed with the aim of identi-
fying difficult areas in TVD and to ensure delineation occurredy tumor, N = Regional Lymph Nodes according to the 7th edition TNM classification.
N M Stage Lymph nodes
1 0 IIB 11L
2 0 IIIA 10R, 7, 8, 4R
0 0 IIB
0 0 IIA
2 0 IIIB 7, 4R, 2R
2 0 IIIA 4R, 2R
0 0 IIB
2 0 IIIA 10R, 4R
nment)
2 0 IIIA 10R, 7, 4R
2 0 IIIA 10R, 7
2 0 IIIA 7, 4R
nment)
Fig. 1. Schematic view of the training program. Over a one year period, 11 pairs of a
radiation oncologist and a nuclear medicine physician performed four contouring
assignments and three more cases for practice, and also attended two training
events. Assessment 1, 2 and cases in Training 1 functioned as baseline measure-
ments. Assessment 2 and 3 contained the same cases and results were compared to
assess the impact of the first training event. Assessment 4 contained one case from
Assessment 1 and two from Training 1 and the results were compared to assess the
impact of the complete training.
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reports were written with the aim of correcting misinterpretations
of the delineation protocol and to advise on specific areas prone to
deviation from the IAEA expert contour. This served as a prelimi-
nary to the webinar which was held as a second training event.
An update on PET/CT-based TVD in RTP and general feedback
was given in the webinar. Afterward the content was discussed
with the group. As a final step participants performed contouring
assignment 4 with three clinical cases, which they had performed
earlier during the training program, eight months after the first
training event.Data analysis
To examine the impact of the training interventions the con-
tours from the participants were analyzed. Various parameters
such as the GTV size, miss of GTVexp, Concordance Index (CI) andFig. 2. Delineation accuracy relative to expert versus intragroup with 95%-CI before
concordance index between the observers’ GTV and the median surface contour. CIexpertsurface mean distance were calculated, and also volumetric and
3-dimensional analysis was performed as described by Deurloo
et al. [27]. The CI is defined as the intersection of two delineated
volumes divided by their union:
CI ¼ ðA \ BÞ
A [ B
The CI can vary between 0 and 1 where 0 means there is a
complete disagreement between the observers and a CI of 1 indi-
cates a perfect agreement [28]. It was calculated for measuring
the delineation accuracy relative to the expert contour (CIexpert).
Intragroup agreement (CIgroup) was also calculated using the
surface median as a reference. The surface median was obtained
as described by Rasch et al. [29]. The mean (absolute) surface
distance between the observers’ GTV and expert GTV and the
distance between each observers’ GTV and surface median were
both calculated. For all parameters, the mean ± SD is reported
unless stated otherwise. Wilcoxon’s signed rank tests were
used to estimate the significance of any differences after the
training events and p-values of 0.05 or less were considered
significant.Results
In all contouring assignments, teams were asked to delineate
GTV of the primary tumor as per study protocol. One of the pairs
with a RO, who was not board certified at the time of the training,
was excluded from the analysis. After the first training event the
overall CIexpert slightly increased from 0.57 ± 0.07 to 0.66 ± 0.07.
The mean CIexpert and CIgroup per case are given in Fig. 2. Observer
volumes were larger after the training and miss of GTVexp was sig-
nificantly reduced from 127.32 ± 42.43 cc to 59.94 ± 48.94 cc. A
detailed summary with p-values is given in Table 2. The overall
mean surface distance and mean absolute surface distance com-
pared to the reference contour decreased from 0.40 ± 0.03 cm
to 0.01 ± 0.33 cm and from 0.47 ± 0.08 cm to 0.45 ± 0.17 cm
respectively. The overall CIgroup decreased from 0.81 ± 0.07 to
0.75 ± 0.10.
After the second teaching event overall CIexpert for another 3
repetitive cases increased from 0.64 ± 0.06 to 0.80 ± 0.05 (see
Fig. 3 for more details). A reduction of GTVexp miss fromand after Training 1 using a standardized delineation protocol. CIgroup = median
= median concordance index between the observers’ GTV and expert GTV.
Table 2
Comparison of results from contouring the GTV before and after the first training event, and before and after a complete training in the use of a standardized delineation protocol.
CIexpert = median concordance index between the observers’ GTV and expert GTV. Mean distance = mean surface distance between the observers’ GTV and expert GTV. Mean |
distance| = mean absolute surface distance.
Case No. Expert volume (cc) Observer volume (cc ± SD) Miss (cc ± SD) CIexpert (±SD) Mean distance (cm ± SD) Mean |distance| (cm ± SD)
Results per case before and after Training 1 (contouring assignment 2 versus 3)
Before 3 388.38 282.75 ± 46.28 127.32 ± 42.43 0.67 ± 0.10 0.41 ± 0.14 0.44 ± 0.13
After 409.48 ± 115.12 59.94 ± 48.94 0.70 ± 0.07 0.05 ± 0.40 0.37 ± 0.23
(p = 0.03) (p = 0.03) (p = 0.34) (p = 0.03) (p = 0.92)
Before 4 50.86 30.58 ± 6.99 20.43 ± 6.09 0.59 ± 0.11 0.27 ± 0.18 0.33 ± 0.10
After 51.35 ± 20.94 8.88 ± 9.34 0.65 ± 0.10 0.11 ± 0.29 0.30 ± 0.10
(p = 0.03) (p = 0.03) (p = 0.06) (p = 0.17) (p = 0.14)
Before 5 164.46 84.93 ± 11.67 84.26 ± 11.66 0.49 ± 0.07 0.64 ± 0.11 0.66 ± 0.12
After 108.49 ± 41.23 62.18 ± 23.14 0.58 ± 0.12 0.43 ± 0.64 0.50 ± 0.45
(p = 0.05) (p = 0.05) (p = 0.08) (p = 0.05) (p = 0.46)
Overall results for 3 repeated cases (contouring assignment 2 versus 3)
Before 123.96 ± 18.35 79.01 ± 17.04 0.57 ± 0.07 0.40 ± 0.03 0.47 ± 0.08
After 191.38 ± 57.29 42.86 ± 25.02 0.66 ± 0.07 0.01 ± 0.33 0.45 ± 0.17
(p = 0.03) (p = 0.05) (p = 0.12) (p = 0.03) (p = 0.75)
Results per case before and after the complete training program (contouring assignment 1 versus 4)
Before 6 377.99 280.39 ± 92.41 115.45 ± 52.16 0.68 ± 0.11 0.41 ± 0.35 0.43 ± 0.19
After 370.78 ± 37.06 26.73 ± 18.34 0.85 ± 0.03 0.01 ± 0.16 0.20 ± 0.09
(p = 0.07) (p = 0.01) (p = 0.01) (p = 0.07) (p = 0.02)
Before 7 254.68 157.99 ± 80.15 103.70 ± 43.86 0.59 ± 0.10 0.55 ± 0.40 0.60 ± 0.16
After 220.24 ± 81.53 39.72 ± 25.87 0.82 ± 0.10 0.18 ± 0.34 0.24 ± 0.18
(p = 0.04) (p = 0.04) (p = 0. 05) (p = 0.07) (p = 0.07)
Before* 1 134.07 78.08 ± 17.60 55.66 ± 9.58 0.56 ± 0.05 0.44 ± 0.17 0.50 ± 0.06
After* 110.20 ± 14.51 26.23 ± 9.68 0.80 ± 0.04 0.19 ± 0.11 0.21 ± 0.04
(p = 0.08) (p = 0.03) (p = 0.05) (p = 0.08) (p = 0.05)
Overall results for 3 repeated cases (contouring assignment 1 versus 4)
Before 190.82 ± 38.07 78.89 ± 22.95 0.64 ± 0.06 0.34 ± 0.16 0.49 ± 0.10
After 246.32 ± 43.11 42.86 ± 25.01 0.80 ± 0.05 0.05 ± 0.20 0.27 ± 0.09
(p = 0.01) (p = 0.01) (p = 0.01) (p = 0.01) (p = 0.01)
* For this case (before and after) two observers were excluded from analysis, because PET positive lymph nodes adjacent to the tumor were included in the GTV of the
primary tumor.
Fig. 3. Delineation accuracy relative to expert versus intragroup with 95%-CI before (blue bar) and after (red bar) a complete training in the use of a standardized delineation
protocol. CIgroup = median concordance index between the observers’ GTV and the median surface contour. CIexpert = median concordance index between the observers’ GTV
and expert GTV. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
42 Multiple training improves PET/CT based target volume delineation in lung cancer78.89 ± 22.95 cc to 42.86 ± 25.01 cc was observed, next to an
increase in observer volume. Overall mean surface distances
between observers and the expert contour decreased from
0.34 ± 0.16 cm to 0.05 ± 0.20 cm. A decrease from 0.49 ±
0.10 cm to 0.27 ± 0.09 cm in overall mean absolute surface distance
was observed. The overall CIgroup increased from 0.80 ± 0.08 to
0.85 ± 0.08. Examples of improvement in IOV and delineation
accuracy before and after the training program are given in Fig. 4
and in supplementary Fig. 1.Discussion
Many studies have reported on the effect of guidelines or proto-
cols and testing of the effect of specific teaching and measured
contouring variability before and after an intervention [30]. This
study is the first to report on the impact of a training program
about the use of the recently published IAEA guidelines for
PET/CT based radiotherapy planning in lung cancer patients in an
international multicenter trial. To the best of our knowledge this
Fig. 4. Results from contouring the GTV in case 6 before (top images) and after (bottom images) the complete training. From left to right an image slice in the axial plane from
CT, PET, and a 3D model of the expert contour with mean surface distance errors projected (from blue to red, corresponding with a mean absolute surface distance of 0
to > 1 cm). The bold red line represents the GTVexp.
T. Konert et al. / Radiotherapy and Oncology 121 (2016) 39–45 43is the first study about the use of multiple teaching interventions
using not only face-to-face training, but also providing an online
learning platform in the form of a webinar which showed to play
an effective role in harmonizing the delineation process globally.
In terms of practicalities of delivering this type of training, the
use of innovative technology such as the delivery of live webinars
may significantly reduce cost without significantly reducing
educational quality. Any economic assessment regarding the cost
benefit ratio undertaking repeated tests of training exceeded the
scope of this study.
Before any training was given, centers delineated their GTV
based on local delineation protocols and thus a variety of
approaches were observed. Results after the first training suggest
that the use of a delineation protocol increased delineation accu-
racy, however a significant reduction in IOV and better adherence
of the outlining protocol were only achieved through additional
extended training.
A major contribution in reducing IOV may have been feedback
participants received from the interim analysis that was performed
before the second training intervention. While it is acknowledged
that the cases selected for the practice case (see Table 1) may have
been more challenging to delineate than the test cases, the use of
these helped identify several areas that caused difficulty in TVD
for the participants. These areas of variation included atelectasis,
PET window level settings, nearby normal structures (e.g. pul-
monary veins or arteries) that were seen as tumor, and/or suspi-
cious areas on CT showing low FDG uptake. These areas ofvariation were documented in the individual feedback reports,
and were also included in the general feedback and discussed dur-
ing the webinar. This may have contributed to the significant
impact on delineation accuracy seen in the last assignment. This
emphasizes the importance of additional training events to correct
errors in delineation still occurring after the first training.
Schimek-Jasch et al. found out that the use of a dummy-run and
study group meetings as part of Quality Assurance (QA) in
multicenter clinical trials helps to identify misinterpretations of a
standardized delineation method which helped in reducing IOV
[32]. However, the outcome of that study did not show a significant
effect which may underline the take-home message of our study
that changing behavior requires multiple and multi-faceted inter-
ventions. Lack of other studies investigating the impact of multiple
training interventions in TVD makes comparison of outcomes
difficult. Further studies with more observers would be needed
to validate the results in this study. Currently the IAEA conducts
a multicenter international study investigating the impact of
blended distance learning (with additional training interventions)
in the field of RT contouring on quality of delineation (CRP
E33040).
Several studies concluded that the use of a standardized delin-
eation protocol helps in decreasing IOV [31,32,34] and our results
concur with that. There was a non-significant increase in IOV seen
after the first training event, however a decrease was noted after
the complete training program. In spite of the first training, visual
inspection with Big Brother showed that some observers misinter-
44 Multiple training improves PET/CT based target volume delineation in lung cancerpreted or did not comply with the guidelines thus their contours
did not more closely resemble the CIexpert contour. Due to the fact
that some observers drew contours more similar to that of the
expert in contrary to others in the group, the CIexpert still increased
slightly. This increase in variation between observers reduced the
CIgroup (see Fig. 2). The second training event was necessary to cor-
rect any misinterpretations of practical guidelines and this
approach of having training interventions may seemmore effective
than a single event training program. This again highlights the dif-
ficulty of changing behavior in order to obtain reproducibility and
underlines the importance of teaching through multiple interven-
tions to improve adherence to contouring guidelines. However,
participants still had difficulties in determining the tumor bound-
ary in cases with suspicious areas showing FDG uptake comparable
to background activity. Decisions, as to whether or not to include
these suspect areas within the GTV, are namely based on experi-
ence and expertise and this contributes to a degree of IOV. This
emphasizes the importance of multidisciplinary meetings in case
the RO experiences difficulties in contouring.
Contrary to the delineation accuracy, GTV size did increase sig-
nificantly among the observers after the first training. This was
mainly due to specific training in standardization of PET window
level settings which is applicable in most commercially available
radiotherapy planning systems [17]. The difficulty with manual
delineation in PET/CT imaging is that the apparent boundaries of
the FDG avid tumor are highly dependent on the chosen PET win-
dow level settings. Tumors will appear larger when delineation
occurs using a high window setting and smaller with a low win-
dow setting on the PET display. Observers were trained in using
standardized PET level window settings consequently showing an
apparently larger tumor than before and this contributed to an
increase in GTV size. Before the 1st training intervention most
delineations were drawn too tightly around the tumor, which
may possibly lead to geographical tumor miss. Caution has to be
taken in circumstances where, in the absence of respiration corre-
lated CT, PET/CT may be substantially less accurate in defining the
motion pathway of highly mobile lung tumors and in tumors with
low FDG uptake [33].
When observers delineate the same tumor repeatedly this cre-
ates systematic errors and contributes to intra-observer variability,
since it is unlikely that any manual contour would be reproduced
identically at different time points. In this study we did not exam-
ine what contribution this effect had on intra-observer variability
when repeating the same case in a short timeframe. However it
is hypothesized this effect is negligible compared to learning
effects over a longer timeframe.
There have been a number of studies which have examined IOV
in TVD using PET based delineation with a number of these studies
focusing on the comparison of automatic delineation methods with
manual delineation [17–21]. Doll et al. used one patient case and
found overall concordance indices between experts, interdisci-
plinary pairs and single field specialists ranging from 0.49 to 0.67
which is similar to our results after the first training [16]. The
experts showed the highest intragroup concordance of 0.67 and
if that is representative then the outcome of our training program
could be seen as successful. However, since the expert group in
Doll et al. only performed one case and the study did not use a
standardized delineation protocol this comparison is not valid. This
study used only one expert contour per case as reference, which
limited the conclusion whether an observer met a certain mini-
mum level of quality in TVD. An intragroup expert concordance
value could help in determining such a minimum required level
of quality. Further research has to determine which deviation from
the intragroup concordance value would be acceptable.
Another limitation was the amount of cases available for the
repeated assignments. Not all cases in Training 1 were suitablefor inclusion in Assessment 4 due to the small tumor size in case
8 and therefore one case of the first assignment (case 1) had to
be included. It is acknowledged that observers were less familiar
with the software in the beginning than later in the training pro-
gram, however the delineation software is similar to any other
delineation tool used in clinic and it is hypothesized that if there
is any learning effect present, this only has an impact on the delin-
eation speed. Above that, a similar increase is seen in all cases after
the complete training suggesting that the learning effect of the
delineation software was negligible (see Fig. 3).
Spoelstra et al. had seen that a significant IOV in contouring
confounded interpretation of post-operative radiotherapy and con-
cluded that Quality Assurance (QA) procedures would need to be
incorporated to tackle this problem [34]. A German multicenter
PET study also covered a similar interesting topic i.e. harmoniza-
tion of diagnostic viewing and reporting and also outlined the
importance of QA [35]. They concluded that a structured interven-
tional harmonization process significantly improved the IOV in
their expert panel. However, no focus had been given on target vol-
ume delineation. In our study, additional training led to an
increased delineation accuracy and decreased the IOV. In clinic,
the IOV should also be assessed in order to see if it is necessary
to provide more training in order to achieve reproducible results
among ROs. Therefore it is recommended that assessment of IOV
should be performed frequently next to having multi-disciplinary
quality control meetings as part of the QA on TVD.
A study examining the influence of experience and qualification
in PET based TVD concluded that IOV may be dependent on qual-
ification, but not on years of experience [16]. It is known that some
centers already had minimal experience in PET/CT-based TVD and
that there were centers with no experience in this field. However,
no significant difference in performance was seen after comparison
of inexperienced versus minimal experienced participants.
Conventional 3-dimensional PET/CT imaging was chosen as the
modality for TVD, since not all participants in the study had expe-
rience in PET/CT-based radiotherapy planning in NSCLC patients.
The impact of 4-dimensional PET/CT has not been investigated
and may be of interest to further increase accuracy. Furthermore,
if a PET/CT acquired for diagnostic or staging purposes is used to
inform the TVD process, care must be taken when registering a
diagnostic PET/CT with a planning CT. Guidance regarding this
has been described in the IAEA study protocol [17].Conclusion
ROs and NMPs with limited experience in PET/CT-based TVD for
lung cancer benefit significantly from receiving multiple training
interventions with a standardized delineation protocol. Future
research within a larger population should validate the results in
this study to provide more evidence on the impact of multiple
training interventions about PET/CT-based TVD for NSCLC.Conflict of interest
None to declare.
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